Based in South San Francisco, 3T Biosciences was founded in 2017. 3T's proprietary 3T-TRACE platform facillitates target discovery and therapeutic development by taking advantage of diverse target libraries and machine-learning algorithms to identify and validate T cell receptor (TCR) targets and specificities.